Cantargia’s research and development to be presented at Biotech Showcase in San Francisco on 9 January 2017
Cantargia AB’s (“Cantargia”) CEO, Göran Forsberg, will be giving a presentation of the company at the Biotech Showcase conference in San Francisco, USA on 9 January at 4 p.m. local time. The presentation will focus on the company’s CAN04 product candidate for non-small cell lung cancer and pancreatic cancer and will also include an introduction to Cantargia’s new CANxx project for autoimmune/inflammatory diseases.Biotech Showcase is an investor and partner conference which gives small and medium-sized biotech companies the opportunity to present themselves and meet investors and commercial